Mavens Biotech Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 16	Mar ' 15	Mar ' 14	Mar ' 13	Mar ' 12

Sales

0.83

1.06

38.18

45.83

45.56

Operating profit

0.27

0.33

0.19

0.93

1.07

Interest

-

-

-

-

-

Gross profit

0.27

0.40

0.29

1.03

1.18

EPS (Rs)

0.01

0.01

0.01

0.06

0.06

Other income

-

0.08

0.11

0.09

0.11

Stock adjustment

-

-

0.04

0.10

0.09

Raw material

-

-

-

-

-

Power and fuel

-

-

-

-

-

Employee expenses

0.22

0.24

0.21

0.24

0.25

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

0.34

0.49

37.74

44.56

44.14

Provisions made

-

-

-

-

-

Depreciation

0.15

0.28

0.22

0.28

0.37

Taxation

0.04

-

0.01

0.04

0.10

Net profit / loss

0.08

0.13

0.07

0.71

0.70

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

10.99

10.99

10.99

10.99

10.99

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

747.00

747.00

747.00

747.00

Agg.of non promotoholding (%)

-

67.96

67.96

67.96

67.96

OPM (%)

32.56

30.74

0.49

2.04

2.34

GPM (%)

-

35.56

.76

2.24

2.58

NPM (%)

-

11.07

0.18

1.54

1.54